← catalyst

PRTA

1 catalyst · 0 upcoming · 0 awaiting · 1 resolved

Resolved

[PDUFA]·Jul 6, 2023
→ FAVORABLE

Lecanemab (Leqembi) — Traditional approval for Alzheimer's disease

▸ analysis · bull/bear · base rate — pro
BIIBLLYPRTAACIU